Clinical Trials Browser

Phase 1/2 × Tuberous Sclerosis × carbon-11 acetate × Clear all

NCT05467397 2026-01-21

Feasibility of [11C]Acetate-PET in LAM and TSC

Phase 1/2 Active not recruiting

7 enrolled 6 charts

Tuberous Sclerosis, Lymphangioleiomyomatosis